Extending this approach, Zhao and colleagues developed EpCAM aptamer-functionalized cationic liposomes (MANPs) for targeted delivery of miR-139-5p, achieving efficient gene silencing and strong tumor inhibition [161]. The gene discussed is EPCAM; the disease is neoplasm.